60 results
F-1
EX-10.26
RDHL
Redhill Biopharma Ltd.
9 Feb 24
Registration statement (foreign)
4:20pm
this Agreement and the Protocol. Such personnel will be qualified by experience, skill, licensure (as appropriate), and training to conduct the Study. Site
424B5
e8vulhaseuqy6hdhnqo
22 Nov 21
Prospectus supplement for primary offering
4:30pm
424B5
u84hey fkiz70w
18 Nov 21
Prospectus supplement for primary offering
4:17pm
6-K
d4agqlat uaq
17 Jun 21
Current report (foreign)
9:11am
424B5
e8k42slezwbbja
3 Mar 21
Prospectus supplement for primary offering
4:31pm
424B5
55zb8h
1 Mar 21
Prospectus supplement for primary offering
4:56pm
6-K
EX-1
lc75gfjg22mv8jb0fg0
25 Mar 20
Current report (foreign)
7:00am
F-3
asvk74
24 Jul 19
Shelf registration (foreign)
7:03am
424B5
ng31k3
23 Jul 19
Prospectus supplement for primary offering
8:31am
6-K
EX-99.1
j3lsjd
28 May 19
RedHill Biopharma Appoints Dr. June Almenoff as Chief Scientific Officer
7:00am
424B5
gp2euhoayvzimj6wy
10 Dec 18
Prospectus supplement for primary offering
12:03pm